Literature DB >> 18650521

Telmisartan, ramipril, or both in patients at high risk of vascular events.

Nikolaus Büchner, Bernhard Banas, Bernhard K Krämer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18650521     DOI: 10.1056/NEJMc081065

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study.

Authors:  Hyoungnae Kim; Seohyun Park; Jong Hyun Jhee; Hae-Ryong Yun; Jung Tak Park; Seung Hyeok Han; Joongyub Lee; Soo Wan Kim; Yeong Hoon Kim; Yun Kyu Oh; Shin-Wook Kang; Kyu Hun Choi; Tae-Hyun Yoo
Journal:  BMC Nephrol       Date:  2019-03-25       Impact factor: 2.388

2.  TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial.

Authors:  Dylan R Morris; Margaret A Cunningham; Anna A Ahimastos; Bronwyn A Kingwell; Elise Pappas; Michael Bourke; Christopher M Reid; Theo Stijnen; Ronald L Dalman; Oliver O Aalami; Jan H Lindeman; Paul E Norman; Philip J Walker; Robert Fitridge; Bernie Bourke; Anthony E Dear; Jenna Pinchbeck; Rene Jaeggi; Jonathan Golledge
Journal:  Trials       Date:  2015-06-17       Impact factor: 2.279

3.  Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct region.

Authors:  Ildiko Toma; Paul J Kim; Rajesh Dash; Michael V McConnell; Dwight Nishimura; Phillip Harnish; Phillip C Yang
Journal:  Cardiovasc Diabetol       Date:  2016-02-05       Impact factor: 9.951

Review 4.  Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone.

Authors:  Hiromi Rakugi; Satoru Yamakawa; Kotaro Sugimoto
Journal:  Hypertens Res       Date:  2020-11-20       Impact factor: 3.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.